Zimmer Biomet Holdings Inc (ZBH) : Tudor Investment Corp Et Al scooped up 4,005 additional shares in Zimmer Biomet Holdings Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Nov 14, 2016. The investment management firm now holds a total of 423,584 shares of Zimmer Biomet Holdings Inc which is valued at $41,506,996.Zimmer Biomet Holdings Inc makes up approximately 1.50% of Tudor Investment Corp Et Al’s portfolio.
Other Hedge Funds, Including , Nicholas Co Inc Wi added ZBH to its portfolio by purchasing 298,095 company shares during the most recent quarter which is valued at $29,210,329. Zimmer Biomet Holdings Inc makes up approx 0.65% of Nicholas Co Inc Wi’s portfolio.Grantham Mayo Van Otterloo boosted its stake in ZBH in the latest quarter, The investment management firm added 6,900 additional shares and now holds a total of 543,531 shares of Zimmer Biomet Holdings Inc which is valued at $54,722,701. Zimmer Biomet Holdings Inc makes up approx 0.27% of Grantham Mayo Van Otterloo’s portfolio.Commerce Bank boosted its stake in ZBH in the latest quarter, The investment management firm added 8,077 additional shares and now holds a total of 193,163 shares of Zimmer Biomet Holdings Inc which is valued at $19,806,934. Zimmer Biomet Holdings Inc makes up approx 0.32% of Commerce Bank’s portfolio.Neuberger Berman Group reduced its stake in ZBH by selling 27,747 shares or 6.57% in the most recent quarter. The Hedge Fund company now holds 394,834 shares of ZBH which is valued at $40,280,965. Zimmer Biomet Holdings Inc makes up approx 0.06% of Neuberger Berman Group’s portfolio. Solaris Asset Management added ZBH to its portfolio by purchasing 110 company shares during the most recent quarter which is valued at $14,079. Zimmer Biomet Holdings Inc makes up approx 0.01% of Solaris Asset Management’s portfolio.
Zimmer Biomet Holdings Inc closed down -0.16 points or -0.16% at $100.64 with 24,09,857 shares getting traded on Monday. Post opening the session at $101.04, the shares hit an intraday low of $100.555 and an intraday high of $101.96 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Zimmer Biomet Holdings Inc reported $1.79 EPS for the quarter, based on the information available during the earnings call on Oct 31, 2016. Analyst had a consensus estimate of $1.79. The company had revenue of $1832.80 million for the quarter, compared to analysts expectations of $1837.65 million. The company’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.
Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. Shares were Upgraded by Needham on Nov 1, 2016 to ” Strong Buy” and Lowered the Price Target to $ 148 from a previous price target of $150 .
Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.